Therefore, it may be that the microenvironment such as higher glycemia and abnormal insulin and epinephrine in T2D mice affects the growth factor secretion pathway of ASCs [17–19, 34–37], which in turn affects the expression and secretion capacity of growth factors in ASCs, resulting in differences in transcriptional regulation. Here, INS is linked to type 2 diabetes mellitus.